FDA clears Medtronic’s catheter for use in the peripheral vascular system

The FDA cleared the TrailBlazer angled support catheter on Sept. 23 for use in the peripheral vascular system.

The catheter, which is manufactured by Medtronic, supports a guide wire during access to the peripheral arties and delivers solutions and diagnostic agents.

The TrailBlazer will be used in endovascular procedures treating complex peripheral artery disease, according to a company news release. The catheter features a stainless steel shaft and a 25- and 30-degree angled tip.